Hematocrit (HCT): Normal Range, What High and Low Mean

If you spun a tube of blood in a centrifuge, the red cells would settle at the bottom and the percentage of the total volume they occupy is the hematocrit. Modern automated CBC analyzers calculate it from the red cell count and average cell size — they do not actually spin the tube — but the number means the same thing.

Hematocrit and hemoglobin track together because each red cell contains a roughly fixed amount of hemoglobin. Discrepancies between them (a low hemoglobin with a "normal" hematocrit, or vice versa) usually point to abnormal cell size — small cells in iron deficiency lower hemoglobin more than hematocrit; large cells in B12 or folate deficiency do the opposite.

• Adult men: 38.8–50.0%
• Adult women: 34.9–44.5%
• Children: ranges shift with age, peaking in newborns (45–65%) and stabilizing into adult ranges by adolescence.
• Pregnancy: physiologically lower (32–42%) due to plasma volume expansion exceeding red cell mass.
• High altitude: baseline is several points higher; people living above ~2,500 m may have hematocrits in the 50s without disease.

Above 50% in men or 45% in women — confirmed and not from dehydration — warrants a workup. Causes:

• Apparent (relative) erythrocytosis — dehydration, diuretic use. Hematocrit looks high because plasma is low; total red cell mass is normal. Most common cause of mildly elevated values.
• Secondary erythrocytosis — the body is making extra red cells in response to low oxygen. Causes: chronic lung disease (COPD, sleep apnea, fibrosis), high altitude, smoking, congenital heart disease, erythropoietin-producing tumors.
• Testosterone replacement therapy — common iatrogenic cause; up to 25% of men on TRT develop erythrocytosis.
• Polycythemia vera — a primary bone marrow disorder where red cell production is autonomous. Diagnosed with low erythropoietin and JAK2 V617F mutation. Affects about 2 in 100,000 adults; treatment usually starts with phlebotomy and aspirin.
• Anabolic steroids — direct erythropoietic effect.

The clinical concern with high hematocrit is hyperviscosity — thicker blood is harder to push, and the risk of thrombosis (heart attack, stroke, deep vein thrombosis) rises with hematocrit above 55–60%. This is why polycythemia vera is treated with periodic phlebotomy to keep the hematocrit below 45%.

Low hematocrit means anemia — the same set of causes as low hemoglobin. The pattern of accompanying values narrows it down:

• Low hematocrit + low MCV → iron deficiency, thalassemia, chronic disease.
• Low hematocrit + high MCV → B12 or folate deficiency, alcohol, hypothyroidism, certain medications.
• Low hematocrit + normal MCV → mixed causes, kidney disease, acute blood loss, chronic disease.
• Low hematocrit + high reticulocytes → blood loss or hemolysis (the marrow is responding).
• Low hematocrit + low reticulocytes → underproduction (deficiency, marrow disease, anemia of chronic disease).

Symptoms of anemia: fatigue, exercise intolerance, palpitations on exertion, pallor, headaches, lightheadedness on standing, cold extremities. These usually appear when hematocrit drops below ~30% in healthy adults; people with cardiopulmonary disease are symptomatic earlier.

Three quick checks before reading a hematocrit:

• Is the patient hydrated? Acute illness with vomiting, diarrhea, or poor intake elevates hematocrit by several points.
• What is the trend? A drop from 42% to 36% across two visits is more important than a single 36% in a patient whose baseline is 36%.
• Does it match the hemoglobin? Hematocrit should be about 3× hemoglobin. Significant divergence suggests an issue with cell size or measurement artifact.

For active follow-up: hematocrit responds to iron repletion in 4–6 weeks, to transfusion within hours, to recovery from acute blood loss over 1–2 weeks once bleeding stops. Resolution of "spurious" dehydration-related elevation happens within 1–2 days of rehydration.

• Hematocrit below 21% — typically warrants transfusion in symptomatic patients or those with cardiopulmonary disease.
• Drop of 5+ percentage points in days — investigate for active bleeding or hemolysis.
• Hematocrit above 55% — workup for polycythemia (erythropoietin level, JAK2 mutation, oxygen saturation, sleep study if applicable).
• Hematocrit above 60% — significant thrombosis risk; phlebotomy often considered.
• On testosterone replacement — monitor every 6 months; reduce dose or pause if hematocrit exceeds 54%.

• Hemoglobin — moves with hematocrit; ratio gives clues to cell size.
• RBC count, MCV, MCH, RDW — full red cell line.
• Reticulocyte count — distinguishes underproduction from increased loss.
• Erythropoietin — low in polycythemia vera, high in secondary erythrocytosis.
• JAK2 V617F mutation — diagnostic for polycythemia vera and other myeloproliferative disorders.
• Ferritin and B12 — when accompanied anemia.